Aptuit to Invest More Than $100 Million in Laurus Labs (India); Dr. Satyanarayana Chava Named Aptuit Laurus CEO, Joins ... (FinanzNachrichten)
Aptuit, Inc. and Laurus ( Nachrichten ) Labs Limited today announced the formation of a new contract drug development company, Aptuit Laurus, which will combine Aptuit ' s global offerings in drug development with Laurus ' R&D and manufacturing expertise and newly built state-of-the-art facilities.

IsoTis Expects Delisting From SWX, Euronext, and TSX in July 2007 (FinanzNachrichten)
IsoTis, ( Nachrichten ) Inc. (NASDAQ: ISOT), the orthobiologics company, today announced that it is at the final stage of concluding the Exchange Offer it launched for all of the outstanding shares of ISOTIS SA on December 15, 2006.

StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial (FinanzNachrichten)
StemCells, ( Nachrichten ) Inc. (NASDAQ: STEM) today announced that the Phase I clinical trial of its proprietary HuCNS-SC product candidate (purified human neural stem cells) has successfully completed enrollment of the low-dose cohort and will proceed to the high-dose cohort.